Search - tctmd.com

Displaying 121 - 140 of 456

Sort: Relevancy | Date

Presentation THT 2024

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

Presenter: Kanika P. Mody

March 06, 2024

Presentation THT Abstracts 2024

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Presenter: Jacob Abraham

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT Abstracts 2024

A Report from the Cardiogenic Shock Working Group on use of Impella 5.0/5.5 for Cardiogenic Shock and Successful Bridge to Recovery, durable LVAD or Heart Transplantation

Presenter: Maryjane Farr

March 05, 2024

Presentation THT 2024

The Impella Portfolio of Devices for Cardiogenic Shock (Left-Sided Support)

Presenter: Justin Fried

March 05, 2024

Presentation THT 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT Abstracts 2024

Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock

Presenter: McKenzie Sicke

March 04, 2024

Presentation THT Abstracts 2024

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Presentation THT Abstracts 2024

ImpellaÆ Use Improves Hemodynamics for Cardiogenic Shock from Ventricular Septal Defect (VSD)

Presenter: Brent Medoff

March 04, 2024

Presentation THT Abstracts 2024

Unloading Effect of Intra-aortic balloon pump and Impella in Venoarterial ECMO Patients

Presenter: Fouad Sakr

March 04, 2024

Presentation THT Abstracts 2024

Enhanced Cardiac Support and Reduced Risks: Evaluating Impella 5.5 in ECPELLA Therapy

Presenter: Ameesh Isath

March 04, 2024

Presentation THT Abstracts 2024

The Impact of Preoperative Impella Support on Left Ventricular Assist Device Survival and Quality of Life

Presenter: Timothy George

March 04, 2024

Presentation THT Abstracts 2024

Assessment of patients with cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation upgrade from Impella 5.5 univentricular support

Presenter: James Schurr

March 04, 2024

Presentation THT 2024

Early Experience With IMPELLA RP Flex

Presenter: Kanika P. Mody

March 04, 2024

Presentation THT 2024

Cardiogenic Shock: The Case for Feasibility and Recovery

Presenter: Aasim Afzal

March 04, 2024

Presentation THT 2024

Achieving Heart Recovery in HF with Cardiogenic Shock

Presenter: Debbie Rinde-Hoffman

March 04, 2024

Presentation THT 2024

Healing Hearts: Achieving Native Heart Recovery

Presenter: Scott Silvestry

March 04, 2024

Presentation THT 2024

Unloading Effect of Intra-aortic balloon pump and Impella in Venoarterial ECMO Patients

Presenter: Fouad Sakr

March 04, 2024

Presentation THT 2024

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

News Daily News

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Michael O'Riordan

February 19, 2024

Advertisement

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

A Report from the Cardiogenic Shock Working Group on use of Impella 5.0/5.5 for Cardiogenic Shock and Successful Bridge to Recovery, durable LVAD or Heart Transplantation

The Impella Portfolio of Devices for Cardiogenic Shock (Left-Sided Support)

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Advanced Therapy Eligibility in Patients with Axillary Impella for Cardiogenic Shock

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

ImpellaÆ Use Improves Hemodynamics for Cardiogenic Shock from Ventricular Septal Defect (VSD)

Unloading Effect of Intra-aortic balloon pump and Impella in Venoarterial ECMO Patients

Enhanced Cardiac Support and Reduced Risks: Evaluating Impella 5.5 in ECPELLA Therapy

The Impact of Preoperative Impella Support on Left Ventricular Assist Device Survival and Quality of Life

Assessment of patients with cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation upgrade from Impella 5.5 univentricular support

Early Experience With IMPELLA RP Flex

Cardiogenic Shock: The Case for Feasibility and Recovery

Achieving Heart Recovery in HF with Cardiogenic Shock

Healing Hearts: Achieving Native Heart Recovery

Unloading Effect of Intra-aortic balloon pump and Impella in Venoarterial ECMO Patients

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content